These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 6235872

  • 1. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
    Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA.
    Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA.
    Nouv Rev Fr Hematol (1978); 1988 Sep; 30(3):155-60. PubMed ID: 2971155
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA, Buchanan MR, Anvari N, Smith LM, Blajchman MA.
    Ann N Y Acad Sci; 1989 Sep; 556():123-31. PubMed ID: 2525356
    [Abstract] [Full Text] [Related]

  • 5. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
    Ofosu FA, Modi GJ, Blajchman MA, Buchanan MR, Johnson EA.
    Biochem J; 1987 Dec 15; 248(3):889-96. PubMed ID: 2963622
    [Abstract] [Full Text] [Related]

  • 6. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF, Ellis V, Seno N, Kakkar VV.
    Biochem J; 1988 Sep 01; 254(2):547-51. PubMed ID: 2902851
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA, Choay J, Anvari N, Smith LM, Blajchman MA.
    Eur J Biochem; 1990 Oct 24; 193(2):485-93. PubMed ID: 2226466
    [Abstract] [Full Text] [Related]

  • 8. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA, Blajchman MA, Modi GJ, Smith LM, Buchanan MR, Hirsh J.
    Br J Haematol; 1985 Aug 24; 60(4):695-704. PubMed ID: 2411283
    [Abstract] [Full Text] [Related]

  • 9. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN, Abildgaard U, Höök M.
    Thromb Res; 1976 Jun 24; 8(6):859-67. PubMed ID: 134464
    [No Abstract] [Full Text] [Related]

  • 10. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
    Ofosu FA, Fernandez F, Gauthier D, Buchanan MR.
    Semin Thromb Hemost; 1985 Apr 24; 11(2):133-7. PubMed ID: 3898370
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.
    Buchanan MR, Boneu B, Ofosu F, Hirsh J.
    Blood; 1985 Jan 24; 65(1):198-201. PubMed ID: 3965047
    [Abstract] [Full Text] [Related]

  • 13. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
    Buchanan MR, Brister SJ.
    Thromb Res; 2000 Sep 15; 99(6):603-12. PubMed ID: 10974347
    [Abstract] [Full Text] [Related]

  • 14. Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.
    Van Ryn-McKenna J, Ofosu FA, Gray E, Hirsh J, Buchanan MR.
    Ann N Y Acad Sci; 1989 Sep 15; 556():304-12. PubMed ID: 2735661
    [Abstract] [Full Text] [Related]

  • 15. Orgaran (Org 10172): its pharmacological profile in experimental models.
    Meuleman DG.
    Haemostasis; 1992 Sep 15; 22(2):58-65. PubMed ID: 1379965
    [Abstract] [Full Text] [Related]

  • 16. Anticoagulant mechanisms of Orgaran (Org 10172) and its fraction with high affinity to antithrombin III (Org 10849).
    Ofosu FA.
    Haemostasis; 1992 Sep 15; 22(2):66-72. PubMed ID: 1379966
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the generation of thrombin and factor Xa by a fucoidan from the brown seaweed Ecklonia kurome.
    Nishino T, Fukuda A, Nagumo T, Fujihara M, Kaji E.
    Thromb Res; 1999 Oct 01; 96(1):37-49. PubMed ID: 10554083
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulant activity of dermatan polysulfates.
    Akiyama F, Seno N, Yoshida K.
    Tohoku J Exp Med; 1982 Apr 01; 136(4):359-65. PubMed ID: 6808700
    [Abstract] [Full Text] [Related]

  • 19. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T, Parkinson JF, Sié P, Bang NU, Müller-Berghaus G, Preissner KT.
    Eur J Biochem; 1991 Jun 15; 198(3):563-70. PubMed ID: 1646716
    [Abstract] [Full Text] [Related]

  • 20. Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans.
    Larsson A, Fransson LA, Lewis WE.
    Thromb Res; 1982 Jun 15; 26(6):401-9. PubMed ID: 7112518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.